In this issue:
Biochemical recurrence and mortality after radiotherapy or radical prostatectomy
Retzius-sparing vs standard RARP
PSMA PET local recurrence concordance with radical prostatectomy histopathology
Predictors of PSMA PET positivity
MRI-based machine learning for Ki67 and Gleason grade group prediction
Niraparib + abiraterone acetate in mCRPC with HRR gene alteration
Cytoreductive radical prostatectomy for bone-metastatic prostate cancer
18F-rhPSMA-7.3 imaging in prostate cancer
PSA-based screening and prostate cancer morbidity and mortality
Free PSA and clinically significant and fatal prostate cancer
Please login below to download this issue (PDF)